Year archive

Kintor Pharmaceutical Limited — 2024 filings

All 38 regulatory filings released by Kintor Pharmaceutical Limited (9939) in 2024, sourced directly from the official regulator.

38 Filings

2024 Period

2024 filings (38)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST SUBJECT ENROLLMENT IN PHASE III STAGE PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA Regulatory Filings	2024-12-30	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Share Issue/Capital Change	2024-11-01	English
VOLUNTARY ANNOUNCEMENT - RECEIPT OF INCI DESIGNATION FOR KT-939 AND COMMITMENT TO EXPAND THE FIELD OF WHITENING AND FRECKLE-REMOVING Regulatory Filings	2024-10-29	English
VOLUNTARY ANNOUNCEMENT - (1) COMPLETION OF FIRST SUBJECT ENROLLMENT IN PIVOTAL CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA; AND (2) UPDATES IN RELATION TO Regulatory Filings	2024-10-16	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2024-10-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Share Issue/Capital Change	2024-10-04	English
INTERIM REPORT 2024 Interim / Quarterly Report	2024-09-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024 Interim / Quarterly Report	2024-08-26	English
DATE OF BOARD MEETING Report Publication Announcement	2024-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-02	English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASES BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER Director's Dealing	2024-07-29	English
VOLUNTARY ANNOUNCEMENT - COSMETICS WITH KX-826 AS THE MAIN INGREDIENT LAUNCH TO MARKET Regulatory Filings	2024-07-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Share Issue/Capital Change	2024-07-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-06-20	English
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 20 JUNE 2024; (2) RETIREMENT OF DIRECTORS; AND (3) CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE Declaration of Voting Results & Voting Rights Announcements	2024-06-20	English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST SUBJECT ENROLLMENT IN PHASE II CLINICAL TRIAL OF GT20029 GEL FOR TREATMENT OF ACNE IN CHINA Regulatory Filings	2024-06-17	English
VOLUNTARY ANNOUNCEMENT - KX-826 Received The INCI Designation Regulatory Filings	2024-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-03	English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF KX-826 TINCTURE 1.0% FOR THE TREATMENT OF MALE ADULT AGA IN CHINA RECEIVED CLEARANCE BY NMPA Regulatory Filings	2024-05-24	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2024-05-21	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-05-21	English
(1) RE-ELECTION OF RETIRING DIRECTORS; (2) RE-APPOINTMENT OF AUDITOR; (3) GENERAL MANDATES TO ISSUE SHARES; AND REPURCHASE SHARES; AND (4) NOTICE OF ANNUAL GENERAL MEETING AGM Information	2024-05-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023 Environmental & Social Information	2024-04-29	English
ANNUAL REPORT 2023 Annual Report	2024-04-29	English
DISCLOSABLE TRANSACTION - RETURN OF LAND USE RIGHT IN PINHU, ZHEJIANG, PRC Capital/Financing Update	2024-04-26	English
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF GT20029 FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA REACHED PRIMARY ENDPOINT Regulatory Filings	2024-04-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Share Issue/Capital Change	2024-04-05	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 Annual Report	2024-03-28	English
DATE OF BOARD MEETING Report Publication Announcement	2024-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-04	English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-22	English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-05	English
VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF KX-826 AND MINOXIDIL COMBINATION THERAPY FOR THE TREATMENT OF MALE AGA RECEIVED CLEARANCE BY CHINA NMPA Regulatory Filings	2024-02-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-02	English

Filings by year

2026 17 filings
2025 43 filings
2024 38 filings
2023 44 filings
2022 61 filings
2021 65 filings
2020 43 filings
2019 2 filings